How to Treat Hodgkin LymphomaKahl, Brad S.Clinical Advances in Hematology & Oncology
Hodgkin lymphoma is one of the two types of cancer that affects the lymphocytes of the body. The other type is non-Hodgkin lymphoma. The two are differentiated by the presence of Reed-Sternberg cells in Hodgkin lymphoma and the fact that this type usually only affects the lymph nodes of ...
Hodgkin Lymphoma: There are only a few types of Hodgkin lymphoma. More likely to affect thelymph nodesin the neck, chest, or underarms Non-Hodgkin Lymphoma: There are numeroustypes and subtypesof non-Hodgkin lymphoma. The majority are diagnosed as B-cell lymphomas or diffuse large B-cell lym...
We wished to determine the incidence of human immunodeficiency virus-related high-grade non-Hodgkin's lymphoma (NHL) and identify factors associated with t... RD Moore,H Kessler,DD Richman,... - 《Jama the Journal of the American Medical Association》 被引量: 170发表: 1991年 Hiv-associated...
Correspondence in reference to the previously published Epub manuscript by Peter Hokland et al. 'How I treat advanced Hodgkin lymphoma – a global view'. Br J Haematol. 2020;190:837–50 M Picardi,C Giordano,RD Pepa,... - 《British Journal of Haematology》 被引量: 0发表: 2021年 ...
Forty-four children aged 3-13 years with Murphy stage III B cell non-Hodgkin's lymphoma were treated between May 1986 and December 1989. All have been followed up for at least 12 months. The primary site was the abdomen in 37 children, 24 of whom had involvement of other organs or noda...
Dopamine is well recognized as a neurotransmitter in the brain, and regulates critical functions in a variety of peripheral systems. Growing research has a
Why I chose to treat and eventually beat my Stage 2 Nodular Lymphocyte Predominant Hodgkin's Lymphoma naturally- without chemotherapy or radiation.
David Maloney, MD, PhD, medical director, Cellular Immunotherapy Integrated Research Center, Fred Hutchinson Cancer Research Center, discusses the results of the ZUMA trial and how chimeric antigen receptor CAR T-cell therapy is changing the treatment landscape for non-Hodgkin lymphoma....
PET-positive bone lesion due to Langerhans cell histiocytosis after BEACOPP therapy for Hodgkin lymphoma: how anamnesis, histopathological accuracy, and molecular analysis could resolve a clinical dilemmaTISSUE woundsBONESHODGKIN'S diseaseLANGERHANS-cell histiocytosis...